Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 8NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 32Lymphoma, Follicular 13Lymphoma, Large B-Cell, Diffuse 12Leukemia, Lymphocytic, Chronic, B-Cell 9Lymphoma, Mantle-Cell 8Burkitt Lymphoma 8Lymphoma, Non-Hodgkin 4Waldenstrom Macroglobulinemia 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Leukemia 3Lymphoma, B-Cell, Marginal Zone 2Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Myelodysplastic Syndromes 1Lymphoma, B-Cell 1Lymphoma, AIDS-Related 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1Dendritic Cell Sarcoma, Interdigitating 1Central Nervous System Neoplasms 1

Interventions

Vincristine 2Prednisone 2Gemcitabine 2Cyclophosphamide 2liposomal amphotericin B 1ixabepilone 1imetelstat 1Watchful Waiting 1VAP-cyclo protocol 1Rituximab 1Radiotherapy 1Palliative Care 1Nutritional Support 1Nicotine 1Moxifloxacin 1Morphine 1Lapatinib 1Everolimus 1Doxorubicin 1Dextromethorphan 1Dexamethasone 1Cytarabine 1Cyclosporins 1Cyclosporine 1Cisplatin 1Ciprofloxacin 1Celecoxib 1Caspofungin 1Analgesia 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Immunoblastic Lymphadenopathy × Rituximab × Clear all
NCT00078949 2023-08-23

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Canadian Cancer Trials Group

Phase 3 Completed
849 enrolled 13 charts
Lymphoid

Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡